pre-seed
Stage
2023
Founded
1
Investors
About
ISOgenix is developing precision medicines that harness the therapeutic potential of protein isoforms, initially focusing on neuromuscular and neurological diseases such as muscular dystrophy.
Explore ISOgenix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.